|
PPP1R3D expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.916000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.200600E-04 |
| Normal-vs-Stage2 |
4.613800E-01 |
| Normal-vs-Stage3 |
6.457600E-01 |
| Normal-vs-Stage4 |
4.282300E-02 |
| Stage1-vs-Stage2 |
2.384200E-01 |
| Stage1-vs-Stage3 |
2.050000E-01 |
| Stage1-vs-Stage4 |
6.178200E-01 |
| Stage2-vs-Stage3 |
8.733600E-01 |
| Stage2-vs-Stage4 |
2.284000E-01 |
| Stage3-vs-Stage4 |
2.594400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.583700E-04 |
| Normal-vs-AfricanAmerican |
5.708100E-02 |
| Normal-vs-Asian |
3.497200E-03 |
| Caucasian-vs-AfricanAmerican |
6.087000E-01 |
| Caucasian-vs-Asian |
1.715000E-01 |
| AfricanAmerican-vs-Asian |
1.224980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.70260000004397E-06 |
| Normal-vs-Female |
4.831000E-01 |
| Male-vs-Female |
3.735600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.002100E-02 |
| Normal-vs-Extreme_Weight |
4.66590000003375E-06 |
| Normal-vs-Obese |
1.165600E-01 |
| Normal-vs-Extreme_Obese |
5.321700E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.318000E-01 |
| Normal_Weight-vs-Obese |
4.715400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.484400E-01 |
| Extreme_Weight-vs-Obese |
2.728400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.816600E-01 |
| Obese-vs-Extreme_Obese |
2.939000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.368200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.561600E-02 |
| Normal-vs-Age(61-80Yrs) |
6.02899999999629E-05 |
| Normal-vs-Age(81-100Yrs) |
7.415800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.576800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.185640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.114100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.459900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.887770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.525200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.16430000005352E-06 |
| Normal-VS-Type2 PRCC |
7.963100E-04 |
| Normal-VS-KIRP CIMP |
9.793800E-01 |
| Normal-VS-Unclassified PRCC |
3.541600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.130800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.732000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.861200E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.402400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.401500E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
6.059000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.826100E-04 |
| Normal-vs-N1 |
6.277400E-01 |
| Normal-vs-N2 |
2.264000E-03 |
| N0-vs-N1 |
7.144100E-03 |
| N0-vs-N2 |
5.778400E-01 |
| N1-vs-N2 |
1.109400E-01 |
|
|
